Acarix USA, Inc.  

287 Park Ave. S Suite 700
New York,  NY  10010

United States
  • Booth: 449

Acarix is a Swedish medical device company that innovates solutions for rapid AI-based rule out of Coronary Artery Disease (CAD). The CE-approved and FDA DeNovo-cleared CADScor®System is intended for patients experiencing chest pain with suspected CAD and is designed to help reduce millions of unnecessary, invasive, costly diagnostic procedures. The CADScor®System uses advanced acoustics and AI technology to rule out CAD non-invasively in less than 10 minutes, with at least 96.2% certainty.

 Additional Info

We will be displaying a new product or promoting a new indication/enhanced feature for an existing product in our booth!
First time Exhibitor?